HIGHLIGHTS
- who: Daniela Rau from the (UNIVERSITY) have published the Article: Assessment of the treating physiciansu2019 first-hand experience with handling and satisfaction of ofatumumab therapy: findings from the PERITIA survey conducted in Europe, in the Journal: (JOURNAL)
- what: As ofatumumab has been recently approved, the findings reported in the current survey provide further cumulative insights from treating physicians about their firsthand experience on the handling and satisfaction of ofatumumab therapy while managing people living with MS. The survey was conducted in European countries and Europe has widely accessible healthcare when compared with other developed countries . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.